News

Fierce Pharma15m
SCOTUS ruling paves smooth launch path for Gilead's long-acting PrEP med Yeztugo, analyst says
As Gilead Sciences gets underway with the key launch of its twice-yearly pre-exposure prophylaxis (PrEP) HIV med, the company ...
The Manila Times32m
Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround
Trinity Biotech projects it reached Adjusted EBITDA1 -positive operations during Q2 2025 and expects to be Adjusted EBITDA1 positive going forward, reflecting continued strong execution on its ...
ET HealthWorld51m
We have drugs to manage HIV. So why are we spending millions looking for cures?
Despite significant advancements in HIV treatment and prevention, researchers continue to seek a cure. This article explores ...
EL PAÍS English54mOpinion
The challenge at UN aid conference: Governments cannot paper over the cracks in development funding
At the United Nations summit in Seville, governments cannot simply cover up the shortcomings of a collapsing developing ...
United Nations Office on Drugs and Crime1h
Tunisia Draws Inspiration from Algeria's Methadone Programme: Advancing Drug Dependence Treatment and Care Through South-South Cooperation
However, treatment options remain limited, as only a small percentage of those affected receive the necessary care. Currently, 11 countries (45%) in the Middle East and North Africa offer opioid ...